7 September 2022
Yellow Cake plc ("Yellow Cake" or the "Company")
Results of 2022 Annual General Meeting
Yellow Cake, a specialist company operating in the uranium sector holding physical uranium ("U3O8") for the long term, is pleased to announce that at the Annual General Meeting of the Company held on 7 September 2022 ("AGM" or the "Meeting") all resolutions were duly passed. Resolutions 1-11 were passed as ordinary resolutions and resolutions 12 and 13 were passed as special resolutions.
The full text of the resolutions passed at the Meeting can be found in the Notice of Annual General Meeting, which is available on the Company's website at www.yellowcakeplc.com.
The following table shows the votes cast on each resolution:
|
| VOTES FOR | % | VOTES AGAINST | % | TOTAL VOTES VALIDLY CAST | % OF SHARE CAPITAL WITH VOTING RIGHTS | VOTES WITHHELD |
1 | Annual Report and Accounts | 83,009,186 | 100.00 | 0 | 0 | 83,009,186 | 45.33 | 125,370 |
2 | Re-appoint Anthony Tudor St John, The Lord St John of Bletso | 75,248,721 | 90.52 | 7,880,269 | 9.48 | 83,128,990 | 45.40 | 5,566 |
3 | Re-appoint Andre Liebenberg | 82,975,435 | 99.82 | 151,833 | 0.18 | 83,127,268 | 45.40 | 7,288 |
4 | Re-appoint Carole Whittall | 82,981,769 | 99.82 | 147,500 | 0.18 | 83,129,269 | 45.40 | 5,287 |
5 | Re-appoint Sofia Bianchi | 82,058,929 | 98.71 | 1,070,340 | 1.29 | 83,129,269 | 45.40 | 5,287 |
6 | Re-appoint Alexander Downer | 82,057,204 | 98.71 | 1,073,178 | 1.29 | 83,130,382 | 45.40 | 4,174 |
7 | Re-appoint Alan Rule | 82,056,925 | 98.71 | 1,072,065 | 1.29 | 83,128,990 | 45.40 | 5,566 |
8 | Re-appoint Emily Manning | 81,825,568 | 98.44 | 1,300,837 | 1.56 | 83,126,405 | 45.40 | 8,151 |
9 | Re-appoint auditor | 83,097,034 | 99.96 | 31,564 | 0.04 | 83,128,598 | 45.40 | 5,958 |
10 | Auditor's remuneration | 83,129,292 | 99.99 | 291 | 0.01 | 83,129,583 | 45.40 | 4,973 |
11 | Authority to allot shares | 71,657,809 | 86.21 | 11,462,542 | 13.79 | 83,120,351 | 45.40 | 14,205 |
12 | Disapply pre-emption rights | 82,209,320 | 98.90 | 916,831 | 1.10 | 83,126,151 | 45.40 | 8,405 |
13 | Authority to purchase own shares | 82,991,003 | 99.99 | 2,618 | 0.01 | 82,993,621 | 45.33 | 140,935 |
Notes:
(1) A vote withheld is not a vote in law and is not counted in the calculation of votes for or against a resolution.
(2) As at close of business on 22 July 2022, being the date used to determine the entitlement of shareholders to attend and vote at the General Meeting, the Company's issued share capital was 187,740,730 Ordinary Shares, the number of Ordinary Shares held in treasury was 4,636,331 and the total voting rights in the Company were therefore 183,104,339.
ENQUIRIES:
Yellow Cake plc | | |
Andre Liebenberg, CEO | Carole Whittall, CFO | |
Tel: +44 (0) 153 488 5200 | | |
Nominated Adviser and Joint Broker: Canaccord Genuity Limited | | |
Henry Fitzgerald-O'Connor | James Asensio | |
Gordon Hamilton Tel: +44 (0) 207 523 8000 | | |
Joint Broker: Berenberg | | |
Matthew Armitt | Jennifer Lee | |
Detlir Elezi | | |
Tel: +44 (0) 203 207 7800 | | |
Financial Adviser: Bacchus Capital Advisers | ||
Peter Bacchus | Richard Allan | |
Tel: +44 (0) 203 848 1640 | | |
Investor Relations: Powerscourt | | |
Peter Ogden | Molly Melville | |
Tel: +44 (0) 7793 858 211 | | |
ABOUT YELLOW CAKE
Yellow Cake is a London-quoted company, headquartered in Jersey, which offers exposure to the uranium spot price. This is achieved through its strategy of buying and holding physical triuranium octoxide ("U3O8"). It may also seek to add value through other uranium related activities. Yellow Cake seeks to generate returns for shareholders through the appreciation of the value of its holding of U3O8 and its other uranium related activities in a rising uranium price environment. The business is differentiated from its peers by its ten-year Framework Agreement for the supply of U3O8 with Kazatomprom, the world's largest uranium producer. Yellow Cake currently holds 18.81 million pounds of U3O8, all of which is held in storage in Canada and France.
FORWARD LOOKING STATEMENTS
Certain statements contained herein are forward looking statements and are based on current expectations, estimates and projections about the potential returns of the Company and the industry and markets in which the Company will operate, the Directors' beliefs and assumptions made by the Directors. Words such as "expects", "anticipates", "should", "intends", "plans", "believes", "seeks", "estimates", "projects", "pipeline", "aims", "may", "targets", "would", "could" and variations of such words and similar expressions are intended to identify such forward looking statements and expectations. These statements are not guarantees of future performance or the ability to identify and consummate investments and involve certain risks, uncertainties and assumptions that are difficult to predict, qualify or quantify. Therefore, actual outcomes and results may differ materially from what is expressed in such forward looking statements or expectations. Among the factors that could cause actual results to differ materially are: uranium price volatility, difficulty in sourcing opportunities to buy or sell U3O8, foreign exchange rates, changes in political and economic conditions, competition from other energy sources, nuclear accident, loss of key personnel or termination of the services agreement with 308 Services Limited, changes in the legal or regulatory environment, insolvency of counterparties to the Company's material contracts or breach of such material contracts by such counterparties. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward looking statements contained herein to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based unless required to do so by applicable law or the AIM Rules.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.